1.Detection and Genotyping of Treponema pallidum by a Nested PCR
Heping ZHENG ; Zhiying OU ; Yushan HU ; Jinmei HUANG ; Meiling LI ; Xingzhong WU ; Weiying ZENG ; Huiqing PAN
Chinese Journal of Dermatology 2003;0(09):-
Objective To develop a nested PCR for the detection of early syphilis and genotyping of Treponema pallidum (TP), and to investigate the distribution of genotypes of TP in Guangzhou. Methods Specimens were consecutively collected from genital ulcers of patients with suspected chancre during 2002-2004, and were detected by dark-field microscopy and nested PCR. The acidic repeat protein (arp) gene and the T. pallidum repeat (tpr) gene family were amplified with the positive specimens above. The number of repeats presented in the arp gene and the restriction fragment length polymorphism by Mse I in the tpr gene were analyzed by electrophoresis. The strains were genotyped according to Pillay's criteria. Results Out of 62 patients with suspected chancre, 33 cases (53.2%) were positive by dark-field microscopy and 54 cases (87.1%) by nested PCR. Of 47 TP-positive specimens genotyped by arp gene, 36 (76.6%) were type 14, while of 49 cases genotyped by tpr gene 39 (79.6%) were type d. By combining genotypes of arp and tpr genes, 7 genotypes were found, including 14d (31, 66.0%), 13d (5, 10.6%), 14b (4, 8.5%), 12b (3, 6.4%), 12d (2, 4.3%), 15d(l, 2.2%) and 14i (1, 2.2%). Conclusions Nested PCR shows a high sensitivity in early detection of TP. Genotype 14d seems the predominant type of TP in Guangzhou.
2.Guben Fangxiao decoction Regulates Expression of CGRP /ILC2 and GABA in Human Bronchial Epithelial Cells Stimulated with IL-4 Combined with IL-13
Weiying OU ; Xuejing YUAN ; Jianjian JI
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(2):93-100
ObjectiveTo observe the effects of Guben Fangxiao decoction-containing serum on the expression of transcription factors and cytokines associated with calcitonin gene-related peptide (CGRP), γ-aminobutyric acid (GABA), and type Ⅱ innate lymphoid cells (ILC2) in human bronchial epithelial cells (BEAS-2B) stimulated with interleukin-4 (IL-4) combined with interleukin-13 (IL-13), and explore the possible mechanism of Guben Fangxiao decoction-containing serum in alleviating type Ⅱ inflammation of bronchial epithelial cells. MethodsBEAS-2B cells stimulated with IL-4 combined with IL-13 were treated with the sera containing high (20%), medium (15%), and low (10%) doses of Guben Fangxiao decoction and the montelukast-containing serum (10%). Real-time PCR was used to measure the mRNA levels of CGRP, GABA, mucin 5AC (MUC5AC), thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, IL-33, IL-5, GATA-binding protein 3 (GATA3), and B cell lymphoma/leukemia 11B (Bcl-11B) in each group. Western blot was employed to determine the relative protein levels of CGRP and MUC5AC. The immunofluorescence assay was employed to observe the relative expression of CGRP and GABA in the cells. Enzyme-linked immunosorbent assay was used to quantify the protein levels of IL-33, MUC5AC, and IL-5 in the culture and cell supernatants. Periodic acid-Schiff staining was performed to assess mucin secretion. ResultsCompared with the control group, the model group showed up-regulated mRNA levels of CGRP, GABA, MUC5AC, TSLP, IL-25, and IL-33 (P<0.05, P<0.01). Compared with the normal group, the Guben Fangxiao decoction-containing serum down-regulated the mRNA levels of CGRP, GABA, MUC5AC, IL-5, GATA3, and Bcl-11B (P<0.05, P<0.01) in a dose-dependent manner. Compared with the normal group, the model group showed up-regulated protein levels of CGRP, GABA, MUC5AC, IL-33, and IL-5 (P<0.05, P<0.01), which were down-regulated by the Guben Fangxiao decoction-containing serum (P<0.05, P<0.01). Compared with the normal group, the model group showed enhanced average fluorescence intensity of CGRP and GABA (P<0.01), which was weakened by the Guben Fangxiao decoction-containing serum (P<0.01). Compared with the normal group, the model group showed increased secretion of mucin, which was reduced by the Guben Fangxiao decoction-containing serum. ConclusionGuben Fangxiao decoction can treat bronchial asthma by alleviating type Ⅱ immune airway inflammation and reducing airway mucus secretion, which is achieved by regulating the expression of CGRP, GABA, MUC5AC, and ILC2-related transcription factors.